In this study, we evaluated the risk of NAFLD and hepatic fibrosis in patients with acromegaly and their association with the noninvasive scores and ANGPTL-8 levels for the first time in the literature. The gene discussed is ANGPTL8; the disease is metabolic dysfunction-associated steatotic liver disease.